Up-regulation of IRF-3 expression through GATA-1 acetylation by histone deacetylase inhibitor in lung adenocarcinoma A549 cells.

Up-regulation of IRF-3 expression through GATA-1 acetylation by histone deacetylase inhibitor in lung adenocarcinoma A549 cells.
复制标题

组蛋白脱乙酰酶抑制剂通过 GATA-1 乙酰化上调肺腺癌 A549 细胞中 IRF-3 的表达

DOI:
10.18632/oncotarget.18371
复制
发表时间:
2017-09-29
期刊:
影响因子:
--
通讯作者:
Zhou GP
Zhou GP
中科院分区:
其他
文献类型:
--
作者:
Wang LL;Zhou LB;Shu J;Li NN;Zhang HW;Jin R;Zhuang LL;Zhou GP

文献摘要

参考文献

相似文献

干扰素调节因子3(IRF-3)是干扰素基因的重要转录因子。尽管病毒感染激活IRF-3基因的功能已被广泛阐明,但对IRF-3基因在癌细胞中表达的调控机制知之甚少。在这项研究中,我们证明了治疗肺腺癌A549细胞与阿司他丁A(TSA)和丙戊酸(VPA),两种不同类别的组蛋白去乙酰化酶抑制剂,强烈刺激IRF-3基因的表达。IRF-3启动子的截短和突变表明,一个特定的加塔-1元件负责TSA诱导的IRF-3启动子的激活。染色质免疫沉淀和电泳迁移率变动分析表明TSA处理增加了加塔-1与IRF-3启动子的结合亲和力。利用免疫沉淀和免疫印迹技术,我们证明TSA增加了A549细胞中乙酰化加塔-1的水平。综上所述,我们的研究表明TSA通过增加肺腺癌A549细胞中加塔-1向IRF-3启动子的募集和加塔-1的乙酰化水平来增强IRF-3基因的表达。
Interferon regulatory factor 3 (IRF-3) is an important transcription factor for interferon genes. Although its functional activation by viral infection has been widely explicated, the regulatory mechanism of IRF-3 gene expression in cancer cells is poorly understood. In this study, we demonstrated treatment of lung adenocarcinoma A549 cells with trichostatin A (TSA) and valproic acid (VPA), two different classes of histone deacetylase inhibitors, strongly stimulated IRF-3 gene expression. Truncated and mutated IRF-3 promoter indicated that a specific GATA-1 element was responsible for TSA-induced activation of IRF-3 promoter. Chromatin immunoprecipitation and electrophoretic mobility shift assay showed that TSA treatment increased the binding affinity of GATA-1 to IRF-3 promoter. Using immunoprecipitation assay and immunoblotting, we demonstrated that TSA increased the level of acetylated GATA-1 in A549 cells. In summary, our study implied that TSA enhanced IRF-3 gene expression through increased GATA-1 recruitment to IRF-3 promoter and the acetylation level of GATA-1 in lung adenocarcinoma A549 cells.
DOI: 10.18632/oncotarget.2999
发表时间: 2015-02-28
期刊: Oncotarget
影响因子: --
作者:
Li Y;Ke Q;Shao Y;Zhu G;Li Y;Geng N;Jin F;Li F
通讯作者: Li F
DOI: 10.1093/nar/gks281
发表时间: 2012-07
影响因子: 14.9
作者:
Bresnick EH;Katsumura KR;Lee HY;Johnson KD;Perkins AS
通讯作者: Perkins AS
DOI: 10.18632/oncotarget.12378
发表时间: 2016-11-01
期刊: Oncotarget
影响因子: --
作者:
Pradhan S;Mahajan D;Kaur P;Pandey N;Sharma C;Srivastava T
通讯作者: Srivastava T
DOI: 10.1038/srep06006
发表时间: 2014-08-08
期刊: Scientific reports
影响因子: 4.6
作者:
Homma T;Ishibashi D;Nakagaki T;Fuse T;Sano K;Satoh K;Atarashi R;Nishida N
通讯作者: Nishida N
DOI: 10.1016/s1097-2765(00)80312-3
发表时间: 1999-02-01
期刊: MOLECULAR CELL
影响因子: 16
作者:
Crispino, JD;Lodish, MB;Orkin, SH
通讯作者: Orkin, SH